Testosterone Replacement Therapy
- 1 January 1998
- journal article
- research article
- Published by Taylor & Francis in Archives of Andrology
- Vol. 41 (2) , 79-90
- https://doi.org/10.3109/01485019808987949
Abstract
The benefits conferred by testosterone replacement therapy are substantial, both in the short term for the eradication of symptoms of androgen deficiency, and in the long term for the prevention of osteoporosis. As with any long-term treatment there are risks that must be considered, but overall the benefits achieved far outweigh potential risk. Ideally, androgen replacement therapy should provide physiological serum testosterone levels, as well as DHT and estradiol levels, and correct the clinical symptoms of androgen deficiency in hypogonadal men. This goal is difficult to achieve because the dose dependency of androgen-dependent physiological processes is not known. Androgen preparations that are currently available do not fulfill all criteria for an ideal androgen replacement therapy. Parenteral testosterone esters are effective, safe, practical, and inexpensive. The transdermal testosterone systems provide an alternative to testosterone esters in selected patients but these preparations are expensive. Ongoing studies are showing the benefits of testosterone replacement therapy in aging men, but there is concern about side effects on cardiovascular system and prostate. Thus, clinical decision regarding testosterone therapy in older men should be better defined.Keywords
This publication has 66 references indexed in Scilit:
- Testosterone Supplementation for Hypogonadal Impotence: Assessment of Biochemical Measures and Therapeutic OutcomesJournal of Urology, 1997
- Pharmacokinetics and pharmacodynamics of subcutaneous testosterone implants in hypogonadal menClinical Endocrinology, 1996
- Effect of testosterone replacement therapy on lipids and lipoproteins in hypogonadal and elderly menAtherosclerosis, 1996
- Age related changes in the pituitary‐testicular axis in normal men; lower serum testosterone results from decreased bioactive LH driveClinical Endocrinology, 1995
- Effect of long‐term oral testosterone undecanoate treatment on prostate volume and serum prostate‐specific antigen concentration in eugonadal middle‐aged menThe Prostate, 1993
- The Influence of Testosterone Substitution on Bone Mineral Density in Patients with Klinefelter's SyndromeExperimental and Clinical Endocrinology & Diabetes, 1992
- Alterations of Lipid Metabolism in Men with HypotestosteronemiaHormone and Metabolic Research, 1991
- Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidencePreventive Medicine, 1991
- Sex, plasma lipoproteins, and atherosclerosis: Prevailing assumptions and outstanding questionsAmerican Heart Journal, 1987
- TRANSDERMAL TESTOSTERONE SUBSTITUTION THERAPY FOR MALE HYPOGONADISMThe Lancet, 1986